Integrating nanorobotics with biophysics for cancer treatment /
"Version: 20240501"--Title page verso.Includes bibliographical references.1. Nanorobotics : materials, design, and technology -- 1.1. Introduction -- 1.2. Nanorobot design and development -- 1.3. Nanorobots designed for a broad spectrum of healthcare uses -- 1.4. The applications of nanorobots in the field of biomedicine -- 1.5. The prospects of nanorobots for use in dentistry -- 1.6. The use of nanorobots in gene therapy -- 1.7. The biocompatibility and toxicity of nanorobots -- 1.8. Conclusions2. Robotics and biophysics : technology advances and challenges in organic and inorganic domains -- 2.1. Introduction -- 2.2. An introduction to the use of robots in the field of biophysics -- 2.3. Technology advances of soft robotics in the organic domain -- 2.4. Developments in inorganic measurement technology -- 2.5. Challenges in integration -- 2.6. Future prospects -- 2.7. Conclusions3. Nanorobots : a primer for deciphering the biophysics of cancer -- 3.1. Introduction -- 3.2. Multiscale cancer biophysics -- 3.3. The biology of cancer cells -- 3.4. The reason for a biophysical strategy for cancer -- 3.5. Nanorobots -- 3.6. Nanorobots for the detection and treatment of cancer -- 3.7. Conclusions4. The biophysics of cancer : management at the nanoscale -- 4.1. Introduction -- 4.2. Important aspects of nanorobots for cancer therapy -- 4.3. Nanorobot propulsion systems for anticancer medicine delivery -- 4.4. Precision cancer diagnosis and treatment with nanorobots -- 4.5. Nanorobots in cancer therapy : potential and clinical problems -- 4.6. Future perspectives and conclusions5. Magnetomechanical systems at the micro/nanoscale for cancer management -- 5.1. Introduction -- 5.2. Cancer therapy using magnetomechanical particles -- 5.3. The magnetomechanical identification of telomerase and nuclear acids in cancerous cells -- 5.4. The therapeutic applications of telomerase studies in cancer -- 5.5. The clinical applications of telomeres and telomerase in oncology -- 5.6. Conclusions6. The role of micro/nanorobotics in personalized healthcare -- 6.1. Introduction -- 6.2. Surgical operations -- 6.3. Diagnosis -- 6.4. Imaging and diagnostic medicine -- 6.5. Prospective view -- 6.6. Regulatory challenges in personalized healthcare -- 6.7. Conclusions7. The development of active nanorobots in personalized healthcare -- 7.1. Introduction -- 7.2. Nanorobots -- 7.3. Nanorobots in healthcare -- 7.4. Applications of nanorobots in personalized healthcare -- 7.5. Future perspectives -- 7.6. Conclusions8. Nanozyme-based nanorobots for cancer treatment applications -- 8.1. Introduction -- 8.2. Nanomedicine and nanotheranostics -- 8.3. Targeted tumor vessel infarction with nanomedicine -- 8.4. Targeted tumor drug delivery systems -- 8.5. Micro- and nanorobots -- 8.6. Difficulties with cancer nanomedicines -- 8.7. Future perspectives -- 8.8. Conclusions9. Progress in the bioelectrochemical and biophysical diagnostic profiling of malignant cancer cells -- 9.1. Introduction -- 9.2. The use of biosensors in clinical assessment -- 9.3. Electrochemical biosensors -- 9.4. Conventional apoptotic and metastatic cell detection methods -- 9.5. Bioelectricity in cancer processes -- 9.6. The detection of bioelectric characteristics -- 9.7. Bioelectrical modifications -- 9.8. Electrification and extracellular vesicles -- 9.9. Biosensors for in vitro cancer cell assessment -- 9.10. Conclusions10. Wireless microrobots : the next frontier in medical advancements -- 10.1. Introduction -- 10.2. Microrobots and their potential therapeutic applications -- 10.3. Targeted therapy -- 10.4. The applications of microrobotics in medicine, particularly in the human cardiovascular system and the bloodstream -- 10.6. Current challenges facing miniaturized biomedical robots and their potential future applications -- 10.7. Methods for the actuation and control of therapeutic microrobots -- 10.8. Conclusions11. Revolutionizing cancer treatment using micro/nanorobotic devices -- 11.1. Introduction -- 11.2. Nano/microrobots for drug delivery -- 11.3. Cancer-targeted drug delivery systems -- 11.4. Conclusions and prospects12. Cyborgs and cyberorgans : biosecurity in biorobotics for healthcare--a case study -- 12.1. Introduction -- 12.2. Biorobotics in healthcare -- 12.3. Cyborgs and cyberorgans in healthcare -- 12.4. Case study -- 12.5. Patent list -- 12.6. Conclusions.Full-text restricted to subscribers or individual document purchasers.In this book, the authors explore the pros and cons of combining biophysics with micro and nanorobots for cancer treatment. This book offers the most recent findings on employing nano/microrobots in biophysics for cancer treatment. Insightful analysis and commentary from the authors complement a comprehensive survey of recent advances and ground-breaking research in the field. Chapters are followed by examples that illustrate the key points or applications of the material covered in that chapter, bridging the gap between the theoretical framework presented here and the rigorous investigation into the subject matter that awaits the reader, once they have mastered the material presented in the book. Part of Biophysical Society-IOP series.Scientists, researchers and clinicians interested in the biophysics of cancer treatment. Bioengineers in the design and implementation of medical nanorobotics and nano-based drug delivery systems.Also available in print.Mode of access: World Wide Web.System requirements: Adobe Acrobat Reader, EPUB reader, or Kindle reader.Rishabha Malviya, did his PhD (Pharmacy) work in the area of novel formulation development techniques. He has 12 years of research experience and presently works as an Associate Professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University. His area of research interest includes formulation optimization, nano formulation, nanorobotic targeted drug delivery, localized drug delivery and characterization of natural polymers as pharmaceutical drugs. He has authored more than 200 research/review papers for national/international journals of repute. He has 51 patents and has received an Outstanding Reviewer award from Elsevier. He has authored/edited/editing more than 70 books (Wiley, CRC Press, Springer Nature, River Publishers, De Gryuter, IOP publishing, Nova Science Publishers and Apple Academic Press) and authored 125 book chapters. His name is included in the world's top 2% of scientists in 2020, 2021 and 2022 by Elsevier and Stanford University. Deepika Yadav completed her Master of Pharmacy from Galgotias University. She is PhD scholar and currently working as Assistant Professor in Sushant University, Gurugram (India). She has contributed several chapters in books published with CRC Press, Taylor and Francis and Wiley. She has published 15 quality articles in prestigious journal. She has also attended more than 8 national and international conferences/Seminar. Sonali Sundram, is currently an Assistant Professor of Pharmacy at Galgotias University (India). Her primary areas of research are in neurodegeneration, clinical research and artificial intelligence. She has authored/edited 30 books with Wiley, CRC Press, Apple Academic Press and River Publishers, more than 50 book chapters and has also authored 30 refereed journal articles. Seifedine Kadry, is a Professor of Data Science in the Faculty of Applied Computing and Technology at Noroff University College, Norway. He is the published author of 12 books with companies such as Elsevier, Springer and Bentham. He has published more than 200 journal articles, largely dealing with Data Science but over the past 5 years has also taken a strong interest in nanorobotics. He is an IEEE Senior Fellow. Prof. Gurvinder Singh Virk is presently Managing Director with Endoenergy Systems Limited aimed at developing wearable assistive exoskeletons to help address the global ageing societal challenges. Endoenergy has bases in Cambridge, United Kingdom and Mohali, India. He has carried out pioneering work in the field of robotics science and engineering and its application to address real-world challenges. He has published around 375 publications in robotics and control engineering, secured over 30M research funding and lead over 50 national and international projects. He has held 13 Professorial positions in 7 countries (UK, France, New Zealand, China, Sweden, Germany and India) and has been a leading actor in ISO/IEC robot standardisation for medical and non-medical robot sectors since 2005. Professor Virk is FIET, CEng, FIMA, CMath, FCIBE and SMIEEE and has been awarded the Freedom of the City of London and is a Liveryman of the Worshipful Company of Information Technology.Title from PDF title page (viewed on June 1, 2024).
No copy data
No other version available